Evidence map›Paper›PMID 39105618›Full record

ArticleImmunotherapy2024

Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy.

Fabiana Perrone, Federica Pecci, Michele Maffezzoli, Giulia Claire Giudice, Valeria Cognigni, Giulia Mazzaschi, Luca Cantini, Luca Santamaria, Francesco Paoloni, Marco Luigi Bruno Rocchi and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Fabiana PerroneMedical Oncology Unit, University Hospital of Parma, Parma.
Federica PecciClinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona.
Michele MaffezzoliMedical Oncology Unit, University Hospital of Parma, Parma.ORCID 0000-0001-7877-8988
Giulia Claire GiudiceMedical Oncology Unit, University Hospital of Parma, Parma.
Valeria CognigniClinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona.
Giulia MazzaschiMedical Oncology Unit, University Hospital of Parma, Parma.
Luca CantiniFortrea, Inc., Durham, NC, USA.
Luca SantamariaClinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona.
Francesco PaoloniClinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona.
Marco Luigi Bruno RocchiBiomolecular Sciences Department, University of Urbino, Urbino, Italy.
Matilde Coriano'Medical Oncology Unit, University Hospital of Parma, Parma.
Alessandro AcunzoMedical Oncology Unit, University Hospital of Parma, Parma.
Federico QuainiDepartment of Medicine & Surgery, Parma, University of Parma, Parma.
Marcello TiseoMedical Oncology Unit, University Hospital of Parma, Parma.
Saini S KamalFortrea, Inc., Durham, NC, USA.
Rossana BerardiClinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona.
Sebastiano ButiMedical Oncology Unit, University Hospital of Parma, Parma.ORCID 0000-0003-0876-0226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyLipidsLymphocytesNeoplasmsNeutrophilsAdultAgedAged, 80 and overFemaleHumansImmune Checkpoint InhibitorsMaleMiddle AgedPrognosisRetrospective StudiesImmune Checkpoint InhibitorsLipidscholesterolimmunotherapylipid metabolismneutrophil-to-lymphocyte ratiosystemic inflammation

Identifiers

PMID39105618
PMCPMC11457594

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.